287 filings
Page 4 of 15
6-K
0opzhmr
27 Dec 10
Ym Biosciences Announces Exercise of Full Over-allotment Option for Total Net Proceeds of Us $43.3 Million
12:00am
6-K
tlynwkn xtq7
21 Dec 10
Current report (foreign)
12:00am
6-K
5s94m46bdsuljs
17 Dec 10
Ym Biosciences Closes Public Offering of Common Shares
12:00am
6-K
eazc ovw8h7s3pz
14 Dec 10
Roth Capital Partners, LLC
12:00am
6-K
bh4wdbcrmen 6t9ioz
14 Dec 10
Ym Biosciences Prices $40 Million Public Offering
12:00am
6-K
vbyfyxqc
14 Dec 10
Current report (foreign)
12:00am
6-K
e46 8agyo31jfl
13 Dec 10
Ym Biosciences Announces Proposed Public Offering of Common Shares
12:00am
6-K
ybazqp6a5xp9aemy9k1x
6 Dec 10
Ym Biosciences Notice of Analyst Meeting and Conference Call
12:00am
6-K
w3hv1xg3h1j02
6 Dec 10
Current report (foreign)
12:00am
6-K
890cs btf9r
6 Dec 10
Ym Biosciences Reports Positive Interim Data Including Substantial Anemia Response
12:00am
6-K
hka xcq9jy81jfs53b
23 Nov 10
Current report (foreign)
12:00am
6-K
l6u1hwnk
18 Nov 10
Current report (foreign)
12:00am
6-K
wdasp7j6
15 Nov 10
YM BioSciences Reports Fiscal First Quarter 2011 Operational and Financial Results
12:00am
6-K
8uxoqpvrj5 lfeud
12 Nov 10
Current report (foreign)
12:00am
6-K
g2u1xpaf 0iu9q6o
8 Nov 10
Results to be presented at the 52nd American Society of Hematology Annual Meeting
12:00am
6-K
1z69kfteul1ms489b
25 Oct 10
Current report (foreign)
12:00am
6-K
w0wir
25 Oct 10
Current report (foreign)
12:00am
6-K
niycf7v8rvz5ydrefg
14 Oct 10
Chief Executive Officer and Announces Annual Meeting
12:00am
6-K
beyhw21q
1 Oct 10
Ym Biosciences to Present Poster on CYT387 at the European
12:00am
6-K
v9xvi8l
29 Sep 10
Ym Biosciences Licensee Pulmokine Awarded Nih
12:00am